Immunosuppressants
Brand/Generic Name
Dosage/Strength
Status
Restrictions
Notes
Relative Cost
CellCept
mycophenolate mofetil
200 mg/mL Suspension for Reconstitution
Not Applicable
CellCept
mycophenolate mofetil
250 mg capsule
Not Applicable
CellCept
mycophenolate mofetil
500 mg tablet
Not Applicable
Gengraf
cyclosporine modified
25 mg capsule; 100 mg capsule
Not Applicable
Hecoria
tacrolimus
0.5 mg capsule; 1 mg capsule; 5 mg capsule
Not Applicable
Imuran
azathioprine
50 mg tablet
$$
Myfortic
mycophenolate sodium
180 mg tablet,delayed release (DR/EC); 360 mg tablet,delayed release (DR/EC)
Not Applicable
Neoral
cyclosporine modified
100 mg capsule; 25 mg capsule
Not Applicable
Neoral
cyclosporine modified
100 mg/mL Solution
Not Applicable
Prograf
tacrolimus
0.5 mg capsule; 1 mg capsule; 5 mg capsule
Not Applicable
Prograf
tacrolimus
5 mg/mL Solution
Not Applicable
Rapamune
sirolimus
0.5 mg tablet; 2 mg tablet; 1 mg tablet
Not Applicable
Rapamune
sirolimus
1 mg/mL Solution
Not Applicable
Sandimmune
cyclosporine
25 mg capsule; 100 mg capsule
Not Applicable
Sandimmune
cyclosporine
250 mg/5 mL Solution; 100 mg/mL Solution
Not Applicable
Zortress
everolimus
0.25 mg tablet; 0.5 mg tablet; 0.75 mg tablet
Not Applicable
Key for Product(s) Listed Above
Formulary
Prior Authorization (PA may not be required for some benefit plans)
Non-Formulary
(Third tier coverage applies for selected plans)
Not Reimbursed
Quantity Limit
Not available through mail order as 90-day supply*
Step Therapy
Generic Available. Brand name medication may be covered at a higher member cost or may not be covered for certain plans.
Notes
$
Relative cost compared to others in category
Specialty distribution for selected plans (Fourth or fifth tier coverage applied for selected plans)
© 2002 Managed Markets Insight and Technology, LLC. All Rights Reserved